The disclosure relates to anthelmintic compositions in the form of a stable granule comprising: (a) levamisole HCL (b) an anthelmintic active selected from (i) one or more imidazothiazoles, (ii) one or more benzimidazoles selected from oxfendazole, albendazole or fenbendazole, (iii) one or more macrocyclic lactones selected from avermectin, ivermectin and abamectin, and (iv) praziquantel (c) a wetting agent and (d) a suspending agent if the anthelmintic actives comprise a benzimidazole or praziquantel and the stable granule being readily dispersible in water to provide a homogenous mixture of the anthelmintic actives for administration to a non-human mammal.
